World Journal of Gastroenterology · 2019 · 50 citations · 25 references
MedicinePharmacotherapyClinical PharmacologyGastroenterologyHemostasisGastrointestinal BleedingGastrointestinal Bleeding ManagementGastrointestinal EndoscopyHemorrhage ControlHemostasis ManagementHemostatic AgentsBleedingEndoscopic Hemostatic DevicesHemostatic Agent UseHemostatic EfficacyHemostatic PowdersPeptic EsophagitisReflux EsophagitisRefractory Peptic Ulcer Disease
BACKGROUND: Gastrointestinal (GI) bleeding is a common indication for endoscopy. For refractory cases, hemostatic powders (HP) represent "touch-free" agents. AIM: To analyze short term (ST-within 72 h-) and long-term (LT-within 30 d-) success for achieving hemostasis with HP and to directly compare the two agents Hemospray (HS) and Endoclot (EC). METHODS: HP was applied in 154 consecutive patients (mean age 67 years) with GI bleeding. Patients were followed up for 1 mo (mean follow-up: 3.2 mo). RESULTS: = 0.04). CONCLUSION: Both HP allow for effective hemostasis with no differences in ST, LT success and re-bleeding.
25
Risk assessment after acute upper gastrointestinal haemorrhage.
Timothy Rockall, Richard F. Logan, Hugh Devlin et al. · Gut · 1996 · 1.5K citations · Full text
Veterinary Medicine, Geriatric Medicine, Clinical Epidemiology +16
Adverse events of upper GI endoscopy
Tamir Ben‐Menachem, G. Anton Decker, Dayna S. Early et al. · Gastrointestinal Endoscopy · 2012 · 373 citations